Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer Launches LabChip® GX and GXII Touch™ Systems

Published: Thursday, July 10, 2014
Last Updated: Thursday, July 10, 2014
Bookmark and Share
New automated platform provides life sciences researchers with precise nucleic acid quantification and protein characterization.

PerkinElmer, Inc. has announced the launch of the new LabChip® GX Touch and GXII Touch™ automated electrophoresis systems.

The LabChip platform’s key feature is automation of conventional gel electrophoresis, eliminating the need for manual sample preparation.

The LabChip GX Touch and GXII Touch benefit customers by reducing hands-on time and simplifying data generation via a user friendly operator touch screen.

The LabChip platform provides the data and throughput necessary to perform effective nucleic acid quantification and protein characterization. The LabChip GX system can enhance genomics research process by precisely quantifying nucleic acids. The GXII Touch system helps to accelerate the development of biotherapeutic drugs by automating the protein characterization process.

“We launched the LabChip platform to provide enhanced workflows for genomics research as well as to speed up the discovery of breakthrough biotherapeutic drugs,” said Brian Kim, President, Life Sciences & Technology, PerkinElmer. “With these two new systems, scientists can harness microfluidics capabilities to obtain results more quickly and efficiently, improve their processes, and make significant research advancements.”

Current Quality by Design (QbD) initiatives underscore the need to identify and understand critical quality attributes, which are features of a therapeutic protein that affect its efficacy. Tight monitoring and control of these attributes helps to ensure stable, more predictable pharmacological response.

The LabChip GXII Touch system’s rapid reporting of multiple protein critical quality attributes can support customer needs throughout the product life cycle.

The LabChip Touch platform’s top differentiator is its ability to perform electrophoresis in microfluidic channels. The LabChip GX Touch system provides rapid, quantifiable data for pre and post-PCR sample analysis, which is critical for next-generation sequencing and genomics workflows.

The LabChip GXII Touch system quantifies protein attributes from process development through quality control in biotherapeutics development and manufacturing.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer Expands Reagent Portfolio for Faster Identification of Epigenetic Drug Candidates
The company announced the launch of four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states.
Tuesday, February 07, 2012
PerkinElmer to Acquire Caliper Life Sciences
PerkinElmer, Inc. announces that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. for a total net purchase price of approximately $600 million.
Wednesday, September 21, 2011
Scientific News
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
The Spice of Life
Scientists discover important genetic source of human diversity.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH-funded study could lead to new tick control methods.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!